Pre program 204 version2

Nov 8, 2010 - Session II “Derivation of iPS-Technology and strategy”. 09:00 – 09:45. Reversible retrovirus-based approaches to reprogramming.
46KB taille 6 téléchargements 297 vues
Les cellules souches pluripotentes induites, reprogrammation et différenciation Human Induced Pluripotent Stem cells, reprogramming and differentiation 8-10 novembre 2010 ◘ Saint-Raphaël / November 8-10, 2010 ◘ Saint-Raphaël

Lundi 8 novembre 2010 ◘ Monday November 8, 2010 16:00 – 18:00

Accueil des participants / Accueil of the participants

Session I “iPSC: The State of the art” 18:00 – 18:15

Introduction by Organizers

18:15 – 19:00

Induction of pluripotency : state of the art Laurence Daheron (Core facility, Harvard University Boston, USA)

2

0

:

0

0

Dîner / Dinner

Mardi 9 novembre 2010 ◘ Tuesday November 9, 2010 07:30 – 09:00

Petit-déjeuner / Breakfast

Session II “Derivation of iPS-Technology and strategy” 09:00 – 09:45

Reversible retrovirus-based approaches to reprogramming Axel Schambach (C. Baum lab, University Hannover, Germany)

09:45 – 10:30

Reprogramming - from Technology to Biology Keisuke Kaji (Centre for Regenerative medicine - MRC, UK)

10:30 – 11:00

Pause-café / Coffee break

11:00 – 11:45 11:45 – 12 :30 12:30 – 14 :00

Derivation And Utility Of Cardiomyocytes From Human Pluripotent Stem Cells Chris Denning (Birmingham University, UK) Defining the barriers of transcription factor mediated reprogramming Rupa Sridharan (K. Plath lab, La Jolla, California, USA) Déjeuner / Lunch

Session III “Reprogramming and SCNT” 14:00 – 14:45

Dissecting the role of signalling inhibition during the induction of pluripotency Jose Silva (Cambridge University, UK)

14:45 – 15:30

Reprogramming by nuclear transfer in the mouse: developmental features of the embryos and stem cell derivation Alice Jouneau (INRA, France)

15:30 – 16:15

Real time monitoring of Sox2 transcription during cell differentiation and nuclear reprogramming Jérôme Jullien (Cambridge University, UK)

16:15 – 16:45

Pause-café / Coffee break

Round Table : Ethics, Regulation & IP 16:45 – 17:05

Intellectual Property rights (IPRs) for induced Pluripotent Stem Cells (iPS) technology Alexandre Simon (INSERM-transfert, France)

17:05 – 17:25

Regulation of Pluripotent Stem Cell Research Laure Coulombel (Inserm, Agence de la Biomédecine, France)

17:25 – 18:30

Round Table / General discussion Moderator: Laure Coulombel (Inserm, Agence de la Biomédecine, France)

19:00 – 19:30

Cocktail / Cocktail

1

9

:

3

0

Dîner / Dinner

Mercredi 10 novembre ◘ Wednesday November 10, 2010 07:30 – 09:00

Petit-déjeuner / Breakfast

Session IV “Differentiation of iPS cells and therapeutic models” 09:00 – 09:45

A Chemical Approach to Controlling Cell Fate Sheng Ding (San Diego University, USA )

09:45 – 10:30

Differentiation from iPS cells: current applications and future hopes Mathilde Girard (I-Stem – Inserm Evry France)

10:30 – 11:00

Pause-café / Coffee break

11:00 – 11:45

Model of liver diseases in vitro using hIPSCs Ludovic Vallier (Cambridge University, UK)

11:45 – 12:30

Hematopoietic Differentiation from Human Pluripotent Stem Cells Annelise Bennaceur-Griscelli (Inserm, University Paris Sud 11, France)

12:30 – 12:45

CONCLUSION

12:45 – 13:30

Déjeuner / Lunch

1

3

:

5

0

Départ des navettes / Departure of the shuttles